TAO Synergies Stock (NASDAQ:TAOX)


OwnershipChart

Previous Close

$3.85

52W Range

$3.30 - $11.98

50D Avg

$4.49

200D Avg

$5.45

Market Cap

$11.93M

Avg Vol (3M)

$156.76K

Beta

1.43

Div Yield

-

TAOX Company Profile


TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.

Show More

Industry

Biotechnology

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

4

IPO Date

Jul 02, 2025

Website

TAOX Performance


Peer Comparison


TickerCompany
INTSIntensity Therapeutics, Inc.
IBIOiBio, Inc.
RLYBRallybio Corporation
KLTOKlotho Neurosciences, Inc.
NXTCNextCure, Inc.
CVKDCadrenal Therapeutics, Inc. Common Stock
BOLDBoundless Bio, Inc.
SONNSonnet BioTherapeutics Holdings, Inc.
ITRMIterum Therapeutics plc
PSTVPlus Therapeutics, Inc.